We are live on ! Find out more
AC

Ascend Capital Portfolio holdings

AUM $1.99B
1-Year Est. Return 10.36%
This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
–
AUM
$2.66B
AUM Growth
+$11.4M
Cap. Flow
-$365M
Cap. Flow %
-13.71%
Top 10 Hldgs %
23.28%
Holding
276
New
116
Increased
46
Reduced
39
Closed
64

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$73.4M
2
WCN
Waste Connections
WCN
+$43.4M
3
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$39.5M
4
AET
Aetna Inc
AET
+$38.9M
5
FANG icon
Diamondback Energy
FANG
+$33.5M

Top Sells

Rank Stock Value
1
LVNTA
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
+$115M
2
PBYI icon
Puma Biotechnology
PBYI
+$65.5M
3
PRU icon
Prudential Financial
PRU
+$64M
4
HST icon
Host Hotels & Resorts
HST
+$61M
5
AMZN icon
Amazon
AMZN
+$47M

Sector Composition

Rank Sector Weight
1 Healthcare 14.44%
2 Technology 12.23%
3 Energy 11.54%
4 Consumer Discretionary 11.15%
5 Industrials 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WCG
201
DELISTED
Wellcare Health Plans, Inc.
WCG
$483K 0.02%
+2,404
New +$465K
SYNT
202
DELISTED
Syntel Inc
SYNT
$459K 0.02%
+20,003
New +$474K
ANAB icon
203
AnaptysBio
ANAB
$1.54B
– –
-44,375
Closed -$1.55M
ASRT
204
DELISTED
Assertio
ASRT
– –
-7,220
Closed -$2.51M
BHF icon
205
Brighthouse Financial
BHF
$3.61B
– –
-160,164
Closed -$9.74M
BMRN icon
206
BioMarin Pharmaceuticals
BMRN
$11.9B
– –
-10,126
Closed -$943K
BMY icon
207
Bristol-Myers Squibb
BMY
$129B
– –
-485,209
Closed -$30.9M
BYD icon
208
Boyd Gaming
BYD
$6.75B
– –
-151,576
Closed -$3.95M
CMP icon
209
Compass Minerals
CMP
$1.23B
– –
-190,146
Closed -$12.3M
COST icon
210
Costco
COST
$432B
– –
-104,258
Closed -$17.1M
DOV icon
211
Dover
DOV
$26.7B
– –
-124,646
Closed -$9.2M
DXC icon
212
DXC Technology
DXC
$1.91B
– –
-189,663
Closed -$14.1M
ETN icon
213
Eaton
ETN
$141B
– –
-109,649
Closed -$8.42M
EZU icon
214
iShare MSCI Eurozone ETF
EZU
$9.38B
– –
-318,870
Closed -$13.8M
FBRX icon
215
Forte Biosciences
FBRX
$1.57B
– –
-99
Closed -$464K
FHN icon
216
First Horizon
FHN
$12.2B
– –
-151,891
Closed -$2.91M
FOLD
217
DELISTED
Amicus Therapeutics
FOLD
– –
-252,522
Closed -$3.81M
GEN icon
218
Gen Digital
GEN
$16.5B
– –
-503,938
Closed -$16.5M
HHH icon
219
Howard Hughes
HHH
$3.94B
– –
-12,693
Closed -$1.43M
HUBB icon
220
Hubbell
HUBB
$24.4B
– –
-28,871
Closed -$3.35M
HWM icon
221
Howmet Aerospace
HWM
$109B
– –
-1,597,980
Closed -$30.5M
IONS icon
222
Ionis Pharmaceuticals
IONS
$8.93B
– –
-134,994
Closed -$6.84M
KHC icon
223
Kraft Heinz
KHC
$32.8B
– –
-106,477
Closed -$8.26M
MEOH icon
224
Methanex
MEOH
$4.23B
– –
-10,126
Closed -$510K
MET icon
225
MetLife
MET
$62.4B
– –
-89,943
Closed -$4.67M
7 8
9
10 11

Similar funds

MWAC
Mariner Wealth Advisors (Cincinnati) Cincinnati, Ohio $1.81B AUM 13.11% 1-Year Est. Return
TP
Tesuji Partners Fort Lee, New Jersey $1.73B AUM 3.93% 1-Year Est. Return
PC
Pomelo Capital New York $1.04B AUM 1.25% 1-Year Est. Return
RW
Rand Wealth Baltimore, Maryland $893M AUM 9.85% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
AC
AFAM Capital Austin, Texas $718M AUM 12.09% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Ascend Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Ascend Capital held 276 positions worth $2.66B, up 0.43% from $2.65B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ascend Capital withdrew a net $365M in Q4 2017, closing 64 positions and reducing 39 holdings. Its most notable exit was Liberty Interactive Corporation Series A Liberty Ventures, an estimated $115M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Energy.

Against the trend, Ascend Capital opened a new position in CVS Health worth $73.2M.

  • Ascend Capital's largest Q4 2017 buy was CVS Health: 1,009,152 shares worth $73.2M.
  • Ascend Capital added most to Waste Connections in Q4 2017, an estimated $43.4M increase.
  • Ascend Capital's biggest Q4 2017 reduction was Puma Biotechnology, cutting an estimated $65.5M.
  • Ascend Capital fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q4 2017, selling an estimated $115M.
  • Ascend Capital's ten largest holdings make up 23% of its $2.66B portfolio in Q4 2017.
  • Ascend Capital opened 116 new positions and closed 64 in Q4 2017.
  • Ascend Capital's portfolio value rose 0.43% quarter-over-quarter to $2.66B.

Based on Ascend Capital's 13F filing for Q4 2017, filed 13 Feb 2018.